![Nathan Hardy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nathan Hardy formerly worked at Amgen, Inc., as Executive Director & Head-Corporate Finance from 2007 to 2017, Juno Therapeutics, Inc., as Vice President-Finance from 2017 to 2018, and Sana Biotechnology, Inc., as Chief Financial Officer & Executive Vice President.
Mr. Hardy received his Masters Business Admin degree from the University of Notre Dame and undergraduate degree from the University of Utah.
Anciens postes connus de Nathan Hardy
| Sociétés | Poste | Fin |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Directeur Financier/CFO | 04/10/2024 |
| JUNO THERAPEUTICS INC | Directeur Financier/CFO | 01/06/2018 |
| AMGEN INC. | Directeur/Membre du Conseil | 01/08/2017 |
Formation de Nathan Hardy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
75
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
